Zenotech Laboratories quarterly results and financials

Zenotech Laboratories (BSE 532039)₹39.00+1.46%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Zenotech Laboratories reported sales of ₹10.60 Cr, up 10.2% from Jun 2025, and net profit of −₹0.45 Cr, down 145.0% year on year. For the year to Mar 2026, sales were ₹43.54 Cr and net profit −₹1.06 Cr.

Sales (Jun 2026): ₹10.60 Cr
Net profit (Jun 2026): −₹0.45 Cr
Sales (FY Mar 2026): ₹43.54 Cr
Net profit (FY Mar 2026): −₹1.06 Cr
EPS (Jun 2026): ₹−0.07
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Zenotech Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Zenotech Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	11.52	10.93	9.09	9.90	9.75	11.23	12.11	9.62	11.22	12.84	9.88	10.60
Expenses	6.02	5.68	6.32	6.47	7.37	7.38	7.65	7.19	8.93	8.60	9.73	9.77
Operating Profit	5.53	5.26	2.77	3.42	2.40	3.86	4.46	2.47	2.30	4.26	0.18	0.85
OPM %	48.0%	48.2%	30.6%	34.7%	24.7%	34.5%	36.9%	25.6%	20.4%	33.3%	1.7%	8.2%
Other Income	0.18	0.27	0.32	0.33	1.68	0.99	0.43	0.58	0.74	0.11	0.64	0.43
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	1.82	1.75	1.74	1.74	1.76	1.77	1.74	1.78	1.79	1.81	1.77	1.91
Profit before tax	3.89	3.79	1.37	2.03	2.34	3.10	3.17	1.27	1.25	2.58	−0.93	−0.59
Tax %	27.1%	11.5%	51.4%	37.2%	42.5%	45.6%	61.2%	22.6%	165.8%	25.4%	235.1%	−25.0%
Exceptional items	0.00	0.00	0.00	0.00	0.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	2.84	3.35	0.67	1.30	1.36	1.70	1.24	1.00	−0.85	1.94	−3.14	−0.45
EPS (Rs)	0.45	0.54	0.10	0.20	0.21	0.27	0.19	0.15	−0.13	0.31	−0.53	−0.07

Zenotech Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Zenotech Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	2.05	2.24	11.13	13.00	26.00	22.40	36.51	42.34	40.76	42.99	43.54	44.54
Expenses	9.72	12.64	19.00	16.55	17.03	16.08	19.10	21.70	23.54	28.86	34.43	37.03
Operating Profit	−7.68	−10.39	−7.86	−3.50	8.97	6.37	17.45	20.70	17.25	14.16	9.20	7.59
OPM %	−372.3%	−462.2%	−70.6%	−26.9%	34.6%	28.5%	47.8%	48.9%	42.4%	33.0%	21.1%	17.0%
Other Income	0.03	1.90	2.36	4.70	7.52	0.40	0.62	1.07	0.95	3.46	2.10	1.92
Interest	7.52	7.47	2.44	0.11	0.88	1.54	1.21	0.10	0.00	0.00	0.00	0.00
Depreciation	3.97	3.88	3.91	4.21	4.86	6.47	6.98	7.18	7.10	6.97	7.12	7.28
Profit before tax	−19.07	−19.78	−11.80	−3.11	10.74	−1.21	9.87	14.47	11.10	10.66	4.18	2.31
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	−124.0%	20.1%	25.4%	47.4%	125.5%	—
Exceptional items	0.00	1.99	0.00	0.00	5.99	0.00	0.00	0.00	0.00	0.99	0.00	0.00
Net Profit	−19.15	−19.86	−11.86	−3.12	10.79	−1.23	22.19	11.60	8.31	5.62	−1.06	−2.50
EPS (Rs)	−3.15	−3.25	−1.93	−0.50	1.76	−0.19	3.62	1.89	1.35	0.91	−0.19	−0.42
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Zenotech Laboratories balance sheet

₹ crore, at each year end.

Zenotech Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	34.49	34.50	34.52	61.15	61.14	61.16	61.17	61.10	61.12	61.08	61.05	61.08
Reserves	−61.81	−80.67	−101	−19.09	−22.20	−11.45	−12.64	9.65	21.33	29.61	35.20	34.19
Borrowings	54.34	54.29	54.33	0.00	20.22	21.41	20.68	6.01	0.00	0.00	0.00	0.00
Other Liabilities	36.81	44.91	62.67	39.70	25.48	14.54	16.85	17.51	18.58	15.61	14.83	15.95
Total Liabilities	63.83	53.03	50.88	81.76	84.64	85.66	86.06	94.27	101	106	111	111
Fixed Assets	52.27	48.29	46.97	44.57	43.25	48.89	74.47	71.15	65.59	65.76	61.01	62.47
CWIP	0.00	0.00	0.00	2.31	16.93	29.04	2.17	0.27	4.97	1.95	3.56	3.59
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	11.56	4.74	3.91	34.88	24.46	7.73	9.42	22.85	30.47	38.59	46.51	45.16
Inventories	2.03	1.58	0.91	0.81	0.57	0.08	0.05	0.05	0.00	0.83	0.00	0.00
Trade receivables	0.41	0.36	0.00	0.00	2.37	1.87	3.81	3.94	3.33	3.26	7.46	8.79
Cash & equivalents	5.77	0.44	0.67	29.04	13.22	1.11	2.45	2.40	11.11	19.61	26.61	30.31
Total Assets	63.83	53.03	50.88	81.76	84.64	85.66	86.06	94.27	101	106	111	111

Zenotech Laboratories cash flow

₹ crore, for each year.

Zenotech Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−7.75	−4.82	1.65	−16.30	−14.09	11.42	5.76	17.75	20.74	11.87	9.53	10.24
Cash from investing activity	0.35	5.51	−0.70	−2.66	−16.22	−20.83	−4.83	−1.85	−5.83	−21.18	15.31	−6.50
Cash from financing activity	6.80	−0.84	−0.73	47.03	15.09	−2.71	0.46	−15.93	−6.14	0.00	0.00	0.00
Net cash flow	−0.61	−0.14	0.24	28.03	−15.27	−12.15	1.39	−0.05	8.77	−9.37	24.84	3.72
Capex	0.04	0.00	0.70	3.81	17.98	21.69	4.90	1.93	6.21	4.22	3.85	8.30
Free cash flow	−7.77	−4.82	0.94	−20.12	−32.13	−10.40	0.84	15.76	14.51	7.61	5.65	1.89
CFO / OP %	38.1%	76.1%	−14.9%	203.1%	387.1%	130.1%	92.1%	107.1%	106.1%	75.1%	81.1%	105.1%

Zenotech Laboratories ratios

Working-capital days and returns, by year.

Zenotech Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	36	62	0	0	66	26	62	39	29	29	63	73
Inventory days	232	304	201	373	293	—	—	—	—	—	—	—
Days payable	222	816	1,128	2,468	2,089	—	—	—	—	—	—	—
Cash conversion cycle	45	−450	−927	−2,095	−1,729	25	61	38	28	28	62	72
Working capital days	−7,876	−17,135	−18,702	−1,220	−1,105	−434	−165	−107	−100	−64	−29	−13
ROCE %	−61.6%	−65.7%	—	−61.9%	−6.0%	8.1%	0.5%	15.2%	18.3%	12.9%	9.3%	4.6%

Zenotech Laboratories: frequently asked questions

What are the latest quarterly results of Zenotech Laboratories?

For the Jun 2026 quarter, Zenotech Laboratories reported sales of ₹10.60 Cr, up 10.2% year on year and net profit of −₹0.45 Cr, down 145.0% year on year. The operating margin was 8.2%.

What is the annual revenue of Zenotech Laboratories?

Zenotech Laboratories' sales for the year to Mar 2026 were ₹43.54 Cr; over the last twelve months they were ₹44.54 Cr.

What is the net profit of Zenotech Laboratories?

Net profit for the year to Mar 2026 was −₹1.06 Cr, and −₹2.50 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.42.

How much debt does Zenotech Laboratories have?

Zenotech Laboratories reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹30.31 Cr.

What is the free cash flow of Zenotech Laboratories?

Cash from operations was ₹10.24 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.89 Cr.

Loading…